AstraZeneca announced that it will make a $100 million research investment at its R&D center near Boston, MA to “strategically boost work in the infectious disease area and continue its incremental growth in cancer research.” The expansion of AZ’s research facility will accommodate as many as 100 additional researchers, who would join the 400+ current employees at the facility. “This investment will significantly boost our research capabilities in two critical area...